Be a crypto hero in the market by logging in

Don't you have an account? Sign in

Token price

  • BTC

    8,949,035.1KRW

    0.0%

  • ETH

    176,472.2KRW

    -0.3%

  • XRP

    270.1KRW

    0.8%

  • USDT

    1,195.1KRW

    0.4%

  • BCH

    250,905.4KRW

    -0.8%

  • LTC

    54,759.1KRW

    -0.5%

  • EOS

    3,231.4KRW

    -0.2%

  • BNB

    18,562.1KRW

    -0.7%

  • BSV

    113,906.3KRW

    -1.1%

  • XLM

    65.8KRW

    0.2%

  • ADA

    45.9KRW

    0.7%

  • XTZ

    1,781.2KRW

    8.4%

  • TRX

    17.3KRW

    -0.9%

  • XMR

    64,952.3KRW

    1.0%

  • HT

    3,350.7KRW

    -0.0%

  • NEO

    10,601.8KRW

    1.5%

  • MKR

    595,388.6KRW

    -1.2%

  • DASH

    62,379.5KRW

    -0.2%

  • USDC

    1,195.0KRW

    0.4%

  • ETC

    4,607.6KRW

    -0.3%

  • ONT

    734.2KRW

    0.2%

  • VET

    8.1KRW

    -4.3%

  • XEM

    42.8KRW

    0.2%

  • DOGE

    2.6KRW

    -0.0%

  • BAT

    224.0KRW

    -2.9%

  • ZEC

    35,153.2KRW

    0.8%

  • PAX

    1,195.6KRW

    0.5%

  • DCR

    24,864.2KRW

    1.5%

  • INB

    641.7KRW

    1.9%

  • QTUM

    2,079.9KRW

    -0.0%

  • RVN

    38.6KRW

    11.0%

  • TUSD

    1,195.9KRW

    0.5%

  • LINK

    485.1KRW

    2.0%

  • ZRX

    279.2KRW

    -2.7%

  • REP

    12,480.6KRW

    0.1%

  • NANO

    980.2KRW

    0.3%

  • CNX

    2,321.8KRW

    -0.7%

  • BTG

    7,160.8KRW

    -0.8%

  • OMG

    891.8KRW

    0.0%

  • XIN

    259,387.3KRW

    1.5%

  • XIN

    259,387.3KRW

    1.5%

  • LSK

    810.7KRW

    -0.2%

  • DGB

    7.7KRW

    -1.6%

  • KCS

    1,156.9KRW

    0.3%

  • BTM

    94.5KRW

    0.2%

  • BTM

    94.5KRW

    0.2%

  • KMD

    789.5KRW

    3.1%

  • XVG

    5.4KRW

    4.9%

  • IOST

    7.2KRW

    1.2%

  • ICX

    161.4KRW

    3.0%

  • THETA

    93.7KRW

    -0.1%

  • BCN

    0.4KRW

    2.2%

  • BCD

    422.5KRW

    -1.6%

  • ENJ

    99.8KRW

    -15.9%

  • MCO

    4,945.2KRW

    -0.9%

  • ZIL

    7.7KRW

    3.8%

  • SC

    1.8KRW

    0.9%

  • MONA

    1,068.9KRW

    -0.6%

  • DAI

    1,185.2KRW

    0.2%

  • WAVES

    685.0KRW

    1.3%

  • BTS

    24.0KRW

    0.4%

  • QNT

    5,434.3KRW

    -6.8%

  • HC

    1,467.8KRW

    -0.3%

  • NEXO

    115.6KRW

    1.4%

  • MAID

    135.0KRW

    0.4%

  • ARDR

    57.1KRW

    -0.1%

  • AE

    192.0KRW

    -1.3%

  • STEEM

    142.0KRW

    -0.5%

  • ETN

    4.6KRW

    0.2%

  • SNT

    13.2KRW

    -1.6%

  • NPXS

    0.2KRW

    -0.0%

  • GNT

    44.1KRW

    0.1%

  • ELF

    73.7KRW

    -1.6%

  • XZC

    4,210.2KRW

    -0.1%

  • STRAT

    355.4KRW

    0.2%

  • AOA

    5.3KRW

    -1.2%

  • PPT

    626.3KRW

    0.4%

  • FCT

    3,512.5KRW

    2.4%

  • ELA

    1,913.2KRW

    -0.0%

  • AION

    82.2KRW

    5.2%

  • WTC

    622.9KRW

    2.9%

  • LRC

    29.3KRW

    1.3%

  • LOOM

    27.4KRW

    9.3%

  • ARK

    220.0KRW

    -0.5%

  • WAX

    25.0KRW

    -3.2%

  • R

    48.5KRW

    -2.1%

  • RDD

    0.8KRW

    -2.6%

  • MOAC

    335.5KRW

    3.8%

  • POWR

    47.7KRW

    1.3%

  • ANT

    644.3KRW

    1.2%

  • PAI

    13.8KRW

    1.0%

  • PAI

    13.8KRW

    1.0%

  • BNT

    318.2KRW

    0.0%

  • DENT

    0.2KRW

    1.7%

  • ODE

    71.0KRW

    -0.4%

  • PIVX

    262.3KRW

    0.7%

  • TTC

    33.1KRW

    0.0%

  • POLY

    27.2KRW

    4.3%

  • PAY

    68.4KRW

    0.8%

  • BAAS

    1.9KRW

    -1.4%

  • MBL

    2.0KRW

    0.0%

  • EOSC

    7.2KRW

    -3.4%

  • BORA

    9.0KRW

    -1.8%

  • CPT

    1.9KRW

    -5.5%

  • REPO

    52.6KRW

    -36.2%

  • APIX

    0.6KRW

    -2.1%

  • FNB

    5.5KRW

    -5.4%

  • COSM

    7.5KRW

    -1.7%

  • GUSD

    1,193.8KRW

    0.2%

  • HUM

    9.4KRW

    10.6%

  • FLETA

    9.7KRW

    0.7%

  • AERGO

    37.9KRW

    -2.7%

  • UPP

    12.3KRW

    -7.7%

  • VRA

    1.1KRW

    5.0%

  • MVL

    0.4KRW

    0.4%

  • DCC

    0.9KRW

    --%

  • LKY

    50.0KRW

    -27.5%

  • eDEL

    2.4KRW

    -0.7%

  • ABL

    8.6KRW

    1.4%

  • MEETONE

    1.1KRW

    -1.9%

  • TEMCO

    0.6KRW

    -3.6%

  • RBG

    0.9KRW

    -0.5%

  • AKRO

    1.8KRW

    3.7%

  • AID

    2.5KRW

    -10.8%

  • WET

    5.6KRW

    -1.9%

  • AMON

    1.7KRW

    -10.8%

  • PXL

    20.9KRW

    9.1%

  • CLB

    1.6KRW

    -2.0%

  • XRA

    6.9KRW

    -0.0%

  • PTON

    0.0KRW

    0.7%

  • KARMA

    0.1KRW

    -5.8%

  • WIKEN

    2.1KRW

    7.2%

  • RBTC

    8,850,002.3KRW

    0.8%

  • SEAL

    0.8KRW

    --%

  • NEWS

    1.2KRW

    -1.8%

  • NPER

    3.5KRW

    --%

  • PUB

    0.2KRW

    -0.1%

  • HORUS

    0.2KRW

    -0.2%

  • CCH

    0.1KRW

    --%

  • PUT

    1.3KRW

    7.0%

  • KNT

    0.0KRW

    -13.3%

  • IQ

    3.1KRW

    -0.1%

  • BLACK

    0.7KRW

    7.0%

  • CET

    18.1KRW

    -1.1%

  • RCD

    3.0KRW

    --%

  • MCC

    0.4KRW

    0.0%

  • INC

    0.2KRW

    -5.5%

  • BZKY

    0.3KRW

    --%

  • CRE

    1.8KRW

    -1.4%

Community

휴먼스케이프, ‘3 day Masterclass in Orphan drugs’ 주최

HUM | 08.05| 318

휴먼스케이프에서 오는 9/24-26일 3일간 진행되는 ‘3 day Masterclass in Orphan drugs’ 강의를 주최합니다.

글로벌 CRO(임상시험수탁기관)인 ‘Parexel’에서 vice president로 근무한 David Schwicker를 연사로 모시고 진행되는 이번 ‘3 day Masterclass in Orphan drugs’ 는

- FDA/EMA에서 희귀의약품으로 지정받는 방법 및 절차 교육’,
- ‘fast to market 방법에 대한 규제적 측면 및 급여화 전략 교육’,
- ‘신약 개발 후 수익 창출 방법 및 시장선점 전략 교육’,
- ‘빠르고 효율적인 희귀의약품 개발을 위한 임상시험 시행 방법 교육’,
- ‘현재 글로벌 희귀질환 시장의 트렌드 및 이슈 논의’ 등

과 같은 희귀질환 치료제의 개발 및 시판에 관한 다양하고 전문적인 주제의 강의와 워크샵으로 구성되어 있으며, 이는 AstraZeneca, Pfizer, Merck, GSK, Sanofi 등 다수의 대형 글로벌 제약 회사에서 수강한 강의와 동일한 컨텐츠입니다.

이번 강의를 통해 IT 기술을 기반으로 성장해 온 휴먼스케이프가 희귀질환 치료제 개발에 대한 보다 전문적인 지식을 쌓을 수 있을 뿐만 아니라, 제약사 및 임상시험기관 등 강의에 참가하시는 많은 관련 업계 전문가분들과 휴먼스케이프 프로젝트에 대한 비전을 나눌 수 있을 것으로 기대합니다.

수강에 관심이 있으신 분들께서는 하기 링크를 클릭하시거나, hailey@humanscape.io로 문의해주시기 바랍니다.

  • 강의 일정: 2019.09.24–26 3일간
  • 강의 장소: Google for Start-ups (강남구 영동대로 417)
  • 강의 신청: http://bit.ly/2Zr4xiD
  • 상세 내용: http://bit.ly/2LTw09D
  • 연사 David Schwicker 약력
    -Founder of ORPHA Strategy Consulting
    -Former Vice President of PAREXEL
    -Founder of Phase IV Programs LLC
    -Co-Founder of Outcomes International, Basel
    -Former Managing Director at Abt Bio-Pharma Solutions Europe

Get to know us better!
Join our official channels below.

Telegram(EN) : t.me/Humanscape
KakaoTalk(KR) : open.kakao.com/o/gqbUQEM
Website : humanscape.io
Medium : medium.com/humanscape-ico
Facebook : www.facebook.com/humanscape
Twitter : twitter.com/Humanscape_IO
Reddit : https://www.reddit.com/r/Humanscape_official
Bitcointalk announcement : https://bit.ly/2rVsP4T
Email : support@humanscape.io


휴먼스케이프, ‘3 day Masterclass in Orphan drugs’ 주최 was originally published in Humanscape on Medium, where people are continuing the conversation by highlighting and responding to this story.

Comment 0

delete

Are you sure you want to delete this post?